CJC-1295 w/o DAC +IPA
$69.99
The CJC/IPA Blend combines CJC-1295 (w/o DAC) and Ipamorelin in a 5 mg + 5 mg configuration, supplied as a 10 mg lyophilized peptide blend for advanced in vitro research. This combination is frequently used to investigate growth hormone (GH) secretagogue pathways, pulsatile GH release, and ghrelin receptor–mediated activity.
- Blend: CJC-1295 (w/o DAC) + Ipamorelin
- Unit Size: 10 mg total (5 mg CJC-1295 w/o DAC + 5 mg Ipamorelin per vial)
- Form: Lyophilized powder
- Storage: Store lyophilized at −20 °C; after reconstitution, refrigerate at 2–8 °C
- Use: For in vitro laboratory research only
In stock
Description
Overview
The CJC/IPA Blend combines two well-characterized peptides commonly utilized in laboratory settings to explore growth hormone secretagogue pathways:
- CJC-1295 (w/o DAC): A tetrasubstituted peptide analogue of growth hormone–releasing hormone (GHRH). The “without DAC” configuration
provides a shorter half-life, making it suitable for modeling pulsatile GH release in vitro rather than extended, long-acting exposure. - Ipamorelin: A selective ghrelin receptor (GHS-R1a) agonist studied for its ability to stimulate GH release in vitro with a relatively
selective profile, showing minimal impact on prolactin or cortisol secretion in experimental systems.
Together, this blend offers researchers a complementary model system for investigating GH-related signaling, receptor selectivity, and combined peptide
effects on pituitary and related cell assays. Each vial contains a total of 10 mg lyophilized peptide (5 mg CJC-1295 w/o DAC + 5 mg
Ipamorelin).
Specifications
- Product Name: CJC-1295 (w/o DAC) + Ipamorelin Research Blend
- Blend Composition: 5 mg CJC-1295 (w/o DAC) + 5 mg Ipamorelin
- Unit Size: 10 mg total peptide per vial
- Form: Lyophilized powder
- Storage (lyophilized): Store at −20 °C in a sealed container, protected from light and moisture.
- Storage (reconstituted): Refrigerate at 2–8 °C and use within a suitable laboratory-defined timeframe.
- Solubility: Soluble in sterile water or compatible aqueous buffers, according to laboratory protocols.
Research Applications
CJC-1295 (w/o DAC) + Ipamorelin is studied in vitro for potential roles in:
- Growth hormone secretagogue pathway modeling
- Pulsatile GH release compared with extended half-life analogues
- Ghrelin receptor agonist selectivity and activity studies
- Synergistic peptide interactions on pituitary and related cell assays
- Comparative peptide pharmacology and receptor signaling researc
For Research Use Only: This compound is offered solely laboratory research. It is not intended for diagnostic, therapeutic, or clinical use. Not for dietary, cosmetic, or veterinary applications.
Disclaimer: All information provided is strictly educational. No claim of efficacy or safety is made. Buyers assume full responsibility for ensuring proper use under federal and local research guidelines.
Terms of Sale: By purchasing from American Wholesale Peptides, you affirm that you are a qualified researcher with the experience to safely handle and store research materials. All sales are final. The supplier is not liable for any misuse, misrepresentation, or unintended outcomes related to this product.
